/ABTI
ABTI Stock - Alterola Biotech, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
52
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.63
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ABTI
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.43
52W High$0.20
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-1,896,981 | $-6,471,134 | $-329,511 | $-258,453 | $-122,557 |
| Net Income | $-1,542,457 | $-6,471,134 | $-171,511 | $-258,702 | $-133,067 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.01 | $-0.00 | $-0.00 | $-0.00 |
Company Overview
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ABTIBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2023
EPS Surprise History
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 27, 2025 | — | — | — | — |
Q3 2025 | Jul 16, 2025 | — | — | — | — |
Q1 2025 | Mar 5, 2025 | — | — | — | — |
Q1 2025 | Feb 28, 2025 | — | — | — | — |
Q4 2024 | Nov 19, 2024 | — | — | — | — |
Q3 2024 | Aug 15, 2024 | — | — | — | — |
Q1 2024 | Feb 20, 2024 | — | — | — | — |
Q4 2023 | Nov 21, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 16, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 5, 2023 | — | $0.00 | — | — |
Q1 2023 | Feb 15, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 21, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 18, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 10, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 1, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 19, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 28, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 19, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 14, 2021 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ABTI
What is ABTI's current stock price?
Alterola Biotech, Inc. (ABTI) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for ABTI?
No analyst price targets are currently available for this stock.
What sector is Alterola Biotech, Inc. in?
Alterola Biotech, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is ABTI's market cap?
Alterola Biotech, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ABTI pay dividends?
No, Alterola Biotech, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBHCCF
Benchmark Holdings plc
$0.37
Mkt Cap: $0.2B
BHHKF
Craftport Cannabis Corp.
$0.00
Mkt Cap: $0.0B
CMVLF
Cellectis S.A.
$4.50
Mkt Cap: $0.3B
CPHRF
Cipher Pharmaceuticals Inc.
$10.60
Mkt Cap: $0.3B
DMTRF
3-D Matrix, Ltd.
$2.37
Mkt Cap: $0.3B
EDTXF
Spectral Medical Inc.
$0.90
Mkt Cap: $0.3B
IDGXF
Integrated Diagnostics Holdings plc
$0.68
Mkt Cap: $0.4B
MAYNF
Mayne Pharma Group Limited
$2.36
Mkt Cap: $0.2B
NIKA
Nika Pharmaceuticals Inc.
$0.28
Mkt Cap: $0.3B
ONVVF
Oneview Healthcare PLC
$0.16
Mkt Cap: $0.1B
Explore stocks similar to ABTI for comparison